BMJ  2004;329:1343-1344 (4 December), doi:10.1136/bmj.329.7478.1343-d

Letter

TADS study raises concerns

The first 150 words of the full text of this article appear below.

EDITOR—We have additional concerns to those raised by Lenzer about the adolescents with depression study (TADS).^{1 2}

TADS consists of two separate randomised studies: a double blind comparison of fluoxetine (109 subjects) with placebo (112), and an unblinded comparison between cognitive behaviour therapy alone (111) and fluoxetine plus cognitive behaviour therapy (107). The lack of patient blinding and placebo control in the latter group is likely to exaggerate the benefit seen in the fluoxetine plus cognitive behaviour therapy group, who receive more face to face contact and know (as do their doctors) that they are not receiving placebo.

Comparing results across all four groups is therefore misleading. The authors' claim that a cognitive behaviour therapy plus placebo arm would have been both too expensive and too artificial to have clinical relevance is unconvincing.

TADS found no statistical advantage of fluoxetine over placebo on the primary end point, the children's . . . [Full text of this article]

Department of Psychological Medicine, Women's and Children's Hospital, North Adelaide 5006, Australia jureidinij@wch.sa.gov.au

University of Adelaide, Adelaide 5005, Australia

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Authors of TADS study reply to letter raising concerns

John S March for the TADS Group
BMJ 2005 330: 730-731. [Extract] [Full Text]

Rethinking childhood depression: Does childhood depression exist?

D B Double
BMJ 2005 330: 418. [Extract] [Full Text] [PDF]

Journalists on Prozac

Jeanne Lenzer
BMJ 2004 329: 748. [Extract] [Full Text]

Efficacy and safety of antidepressants for children and adolescents

Jon N Jureidini, Christopher J Doecke, Peter R Mansfield, Michelle M Haby, David B Menkes, and Anne L Tonkin
BMJ 2004 328: 879-883. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• The TADS Team, (2007). The Treatment for Adolescents With Depression Study (TADS): Long-term Effectiveness and Safety Outcomes. Arch Gen Psychiatry 64: 1132-1143 [Abstract] [Full text]  
• TONKIN, A., JUREIDINI, J. (2005). Wishful thinking: antidepressant drugs in childhood depression. Br. J. Psychiatry 187: 304-305 [Full text]  
• March, J. S, for the TADS Group, (2005). Authors of TADS study reply to letter raising concerns. BMJ 330: 730-731 [Full text]  
• Double, D B (2005). Rethinking childhood depression: Does childhood depression exist?. BMJ 330: 418-418 [Full text]  

Rapid Responses:

Read all Rapid Responses

TADS critiques lack scientific rigor, accuracy and thus credibility

John S. March, et al.
bmj.com, 24 Dec 2004 [Full text]